Aaf Kuijper

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jan van den Berg, Louis B. Bartels, H. Heidbuchel, 2022, The Lancet.

Celiprolol vs Propranolol in Unstable Angina Pectoris: A Double-Blind, Randomized, Parallel-Group Study

T. Cleophas, K. Zwinderman, H. Remmert, 1995, Angiology.

Celiprolol and propranolol for unstable angina pectoris

T. Cleophas, K. Zwinderman, H. Remmert, 1995, Clinical pharmacology and therapeutics.

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study.

Jan van den Berg, H. Heidbuchel, S. Connolly, 2022, Lancet.